Point72 Asia (Singapore)’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$11.5K	Sell	566 -1,232	-69%	-$25.1K	﹤0.01%	787
2025 Q1	$32.6K	Buy	+1,798	New	+$32.6K	0.01%	632
2024 Q4	–	Sell	-1,210	Closed	-$41.1K	–	918
2024 Q3	$41.1K	Sell	1,210 -843	-41%	-$28.6K	0.01%	724
2024 Q2	$76K	Buy	+2,053	New	+$76K	0.02%	550